Assessing prognosis for high-grade soft-tissue sarcomas: Search for a marker

Annals of Surgical Oncology

Volumn 3, Issue 6, 1996, Pages 550-557

  Mankin, Henry J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Flow cytometry; Prognosis; Sarcoma; Soft tissue

Indexed keywords

TUMOR MARKER;

AGE; ARTICLE; FEMALE; HUMAN; MALE; METASTASIS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMA; SEX DIFFERENCE; SOFT TISSUE TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

AGE FACTORS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOMA; SEX FACTORS; SOFT TISSUE NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0030276806     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02306088     Document Type: Article

References (5)

1. Eilber RR, Huth JF, Mirra J, Rosen G. Progress in the recognition and treatment of soft tissue sarcomas. Cancer 1990;65:660-6.
2. Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop 1980;153:106-20.
3. Greenfield GB, Arlington JA, Kudryk BT. MRI of soft tissue tumors. Skel Radiol 1993;22:77-84.
4. Hoekstra HJ, Boeve WJ, Kamman RL, Mooyaart EL. Clinical applicability of human in-vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors. Ann Surg Oncol 1994;1:504-11.
5. Hogeboom WR, Hoekstra HJ, Mooyaart EL, et al. MRI and CT in the preoperative evaluation of soft-tissue tumors. Arch Orthop Trauma Surg 1991;110:162-1.